World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00451594
Date of registration: 22/03/2007
Prospective Registration: No
Primary sponsor: Cooperative Study Group A for Hematology
Public title: High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
Scientific title: A Randomized Controlled Multicentre Trial of High Dose Dexamethasone Versus Conventional Dose Prednisolone for Adults With Untreated Idiopathic Thrombocytopenic Purpura
Date of first enrolment: September 2005
Target sample size: 157
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00451594
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 3
Countries of recruitment
Korea, Republic of
Contacts
Name:     Sung Hwa Bae, professor
Address: 
Telephone:
Email:
Affiliation:  Daegu Catholic Univertity Hospital, ROK
Name:     Jung-Hee Lee, professor
Address: 
Telephone:
Email:
Affiliation:  Asan Medical Center, ROK
Key inclusion & exclusion criteria

Inclusion Criteria :

- a true thrombocytopenia on blood smear

- adequate megakaryopoiesis on bone marrow examination

- the absence of clinically apparent associated conditions or cause of
thrombocytopenia

- Age over 16 years

- A platelet count of less than 30x109/L

Exclusion criteria :

- previous treatment for ITP.

- other causes of thrombocytopenia such as HIV infection, lymphproliferative disease,
liver disease, or definite SLE.

- Patients with life threatening bleeding and pregnant women should be excluded.



Age minimum: 16 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Idiopathic Thrombocytopenic Purpura
Intervention(s)
Drug: Prednisolone
Drug: Dexamethasone
Primary Outcome(s)
response rate and platelet count [Time Frame: 6 years]
Secondary Outcome(s)
Secondary ID(s)
C-009
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history